Non-Billable / Non-Specific Code
ICD-10-CM C83.5 is the diagnosis code for Lymphoblastic (diffuse) lymphoma. This code falls under the section "Malignant neoplasms of lymphoid, hematopoietic and related tissue" within Chapter 2 — Neoplasms (C00-D49). It is a non-billable/non-specific ICD-10-CM code that should not be used for reimbursement. A more specific sub-code is required for billing. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Understanding where C83.5 sits in the ICD-10-CM classification helps ensure proper coding:
No, C83.5 is a non-billable/non-specific code. You should use a more specific sub-code for billing and reimbursement.
C83.5 is the ICD-10-CM diagnosis code for "Lymphoblastic (diffuse) lymphoma". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of C83.5 is C83 ("Non-follicular lymphoma"). C83.5 provides a more specific classification within this category.
C83.5 is located in Section C81-C96 — "Malignant neoplasms of lymphoid, hematopoietic and related tissue" within Chapter 2 of the ICD-10-CM Tabular List.
C83.5 has 11 sub-code(s) that provide more specific detail: C83.50, C83.51, C83.52, C83.53, C83.54 and more.
Use C83.5 when the patients documented diagnosis matches "Lymphoblastic (diffuse) lymphoma" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Lymphoblastic (diffuse) lymphoma is C83.5.
No, C83.5 is non-billable. Use a more specific sub-code for primary diagnosis billing.
C83.5 is in Chapter 2 of the ICD-10-CM Tabular List.
Yes, C83.5 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.